These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1742225)

  • 1. Cisplatin and etoposide in advanced colorectal carcinoma.
    Passalacqua R; Bisagni G; Cocconi G; Boni C; Di Blasio B; Ceci G
    Ann Oncol; 1991 Oct; 2(9):687-8. PubMed ID: 1742225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.
    Greco FA; Johnson DH; Hainsworth JD
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):14-8. PubMed ID: 1492223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
    Paccagnella A; Favaretto A; Brandes A; Ghiotto C; Fornasiero A; Volpi A; Pappagallo G; Festi G; Cipriani A; Vinante O
    Cancer; 1990 Jun; 65(12):2631-4. PubMed ID: 2160312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin and chronic oral etoposide as salvage therapy for advanced colorectal carcinoma.
    Stuart K; Posner M; Campbell K; Huberman M
    Am J Clin Oncol; 1995 Aug; 18(4):300-2. PubMed ID: 7625370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.
    LoRusso P; Pazdur R; Redman BG; Kinzie J; Vaitkevicius V
    Am J Clin Oncol; 1989 Dec; 12(6):486-90. PubMed ID: 2686394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
    Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma.
    Posner M; Slapak CA; Browne MJ; Clark JW; Curt G; Weitberg A; Calabresi P; Cummings FJ; Wiemann M; Urba S
    Am J Clin Oncol; 1990 Oct; 13(5):455-8. PubMed ID: 2220666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.
    Dhingra HM; Valdivieso M; Booser DJ; Umsawasdi T; Carr DT; Chiuten DF; Murphy WK; Issell BF; Spitzer G; Farha P
    Cancer Treat Rep; 1984 Apr; 68(4):671-3. PubMed ID: 6538811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinoma.
    Scheithauer W; Depisch D; Schiessel R; Ludwig H
    Oncology; 1989; 46(4):217-21. PubMed ID: 2787010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin plus VP 16-213 in advanced ovarian carcinoma.
    Harnett PR; Bell DR; Hillcoat BL; Woods RL; Levi JA; Rome RM; Campbell JC; Tattersall MH
    Gynecol Oncol; 1988 Jun; 30(2):159-62. PubMed ID: 3371739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of methotrexate, etoposide and cisplatin in the treatment of urothelial cancer.
    Igawa M; Kadena H; Tacho T; Nakamoto T; Usui T
    Urol Int; 1995; 54(2):80-4. PubMed ID: 7747364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cisplatin in advanced colorectal cancer resistant to 5-fluorouracil plus (S)-leucovorin.
    Cassano A; Pozzo C; Corsi DC; Fontana T; Noviello MR; Astone A; Barone C
    J Cancer Res Clin Oncol; 1995; 121(8):474-7. PubMed ID: 7642690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer.
    Elliott TE; Moertel CG; Wieand HS; Hahn RG; Gerstner JB; Tschetter LK; Mailliard JA
    Cancer; 1990 Apr; 65(7):1491-4. PubMed ID: 2311061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin and etoposide in advanced colorectal carcinoma. A phase II study.
    Jeremic B; Acimovic L; Mijatovic L
    Cancer; 1993 May; 71(9):2706-8. PubMed ID: 8467452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary.
    Voog E; Merrouche Y; Trillet-Lenoir V; Lasset C; Peaud PY; Rebattu P; Negrier S
    Am J Clin Oncol; 2000 Dec; 23(6):614-6. PubMed ID: 11202809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
    Shepherd FA; Evans WK; Goss PE; Latreille J; Logan D; Maroun J; Stewart D; Warner E; Paul K
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):54-8. PubMed ID: 1329213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.